Contribution of the addition of anti-β2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome

References

• Rand JH. The antiphospholipid syndrome. Annu Rev Med 2003;54:409–424.
   PubMedGoogle Scholar
• Galli M. Antiphospholipid syndrome: association between laboratory tests and clinical practice. Pathophysiol Haemost Thromb 2003/2004;33:249–255.
   PubMed Web of Science ®Google Scholar
• Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome:report of an international workshop. Arthritis Rheum 1999;42:1309–1311.
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295–306.
   PubMed Web of Science ®Google Scholar
• Zohlami-Rintelen C, Vormittag R, Sailer T, Lehr S, Quehenberger P, Rumpold H, Male C, Pabinger I. The presence of IgG antibodies against β2 glycoprotein I predicts the risk of thrombosis in patients with lupus anticoagulant. J Thromb Haemost 2005;3:1160–1165.
   PubMedGoogle Scholar
• Levy RA, Avvad E, Oliveira J, Porto LC. Placental pathology in antiphospholipid syndrome. Lupus 1998;7:81–85.
   PubMedGoogle Scholar
• Lockshin MD. Pregnancy loss and antiphospholipid antibodies. Lupus 1998;7:86–89.
   PubMedGoogle Scholar
• Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. Birth weight standards in the live-born population in Israel. Isr Med Assoc J 2005;7:311–314.
   PubMed Web of Science ®Google Scholar
• Report on the National High Blood Pressure Education Program Working Group On High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–S22.
   PubMed Web of Science ®Google Scholar
• Brandt JT, Triplett DA, Alvin B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74:1185–1190.
   PubMed Web of Science ®Google Scholar
• Pengo V, Biasiolo A, Rampazzo P, Brocco T. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-β2-Glycoprotein-I autoantibodies. Thromb Haemost 1999;81:256–258.
   PubMed Web of Science ®Google Scholar
• Tincani A, Allegri F, Balestrieri G, Sanmarco M, Meroni P, Boffa MC. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004;114:553–558.
   PubMed Web of Science ®Google Scholar
• Reber G, Tincani A, Sanmarco M, de Moerloose P, BoffaMC; Standardization group of the European Forum on Antiphospholipid Antibodies. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004;2:1860–1862.
   PubMed Web of Science ®Google Scholar
• Falcon CR, Martinuzzo ME, Forastiero RR, Cerrato GS, Carreras LO. Pregnancy loss and autoantibodies against phospholipid-binding proteins. Obstet Gynecol 1997;89:975–980.
   PubMedGoogle Scholar
• Lynch A, Byers T, Emlen W, Rynes D, Shetterly SM, Hamman RF. Association of antibodies to beta2-glycoprotein 1 with pregnancy loss and pregnancy-induced hypertension:a prospective study in low-risk pregnancy. Obstet Gynecol 1999;93:193–198.
   PubMedGoogle Scholar
• Chamley LW, Duncalf AM, Mitchell MD, Johnson PM. Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998;352:1037–1038.
   PubMed Web of Science ®Google Scholar
• Jankowski M, Vreys I, Wittevrongel C, Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in hamster. Blood 2003;101:157–162.
   PubMed Web of Science ®Google Scholar
• Molad Y, Borkowski T, Monselise A, Ben-Haroush A, Sulkes J, Hod M, Feldberg D, Bar J. Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies. Lupus 2005;14:145–151.
   PubMedGoogle Scholar
• Danowski A, Kickler TS, Petri M. Anti β2 glycoprotein I:Prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 2006;33:1775–1779.
   PubMed Web of Science ®Google Scholar
• Mok MY, Chan EY, Fong DY, Leung KF, Wong WS, Lau CS. Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus. J Rheumatol 2005;32:622–628.
   PubMedGoogle Scholar
• Laskin CA, Spitzer KA, Clark CA, Low molecular weight heparin and aspirin for the recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J Rheumatol 2009;36:279–287.
   PubMed Web of Science ®Google Scholar
• Ness RB, Harris T, Cobb J, Flegal KM, Kelsey JL, Balanger A, Stunkard AJ, D'Agostino RB. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 1993;328:1528–1533.
   PubMed Web of Science ®Google Scholar
• Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002;325:157–160.
   PubMed Web of Science ®Google Scholar